Spotlight on the June 14 Issue

Spotlight on the June 13 issue.

Brain reserve and cognitive reserve in multiple sclerosis: What you’ve got and how you use it Sixty-two patients with multiple sclerosis received MRIs to estimate brain reserve, estimatedwith intracranial volume and disease burden. The authors provided evidence of cognitive reserve independently protecting against disease-related cognitive decline over and above brain reserve. Lifestyle choices...

Spotlight on the March 14 issue.

Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial: Main results Patients with carotid occlusion and hemodynamic failure had cognitive function measured before and after surgical vs medical intervention. Mild cognitive impairment at baseline improved over 2 years, but improvement did not depend on treatment group. There is a growing recognition that cerebral hemodynamic...

Volume 14 , Issue 24 - 18 June 2009

Spotlight on the July 11 issue.

Recurrent thromboembolic events after ischemic stroke in patients with cancer The authors identified 263 patients with active systemic cancer diagnosed with acute ischemic stroke at a cancer center. Despite a median survival of 84 days, 90 patients had 117 recurrent thromboembolic events. Patients with acute ischemic stroke with active cancer faced a substantial short-term risk of recurrent str...

Spotlight on the November 15 issue.

Adherence to antihypertensive agents after ischemic stroke and risk of cardiovascular outcomes The authors examined 14,227 patients with ischemic stroke who were treated with antihypertensive (AH) agents. Each case was matched to 15 controls. Adherence to AH agents was associated with adherence to other secondary preventive therapies and a risk reduction for nonfatal vascular events after an is...